The Ubiquitin Ligase Stub1 Negatively Modulates Regulatory T Cell Suppressive Activity by Promoting Degradation of the Transcription Factor Foxp3  by Chen, Zuojia et al.
Immunity
ArticleThe Ubiquitin Ligase Stub1 Negatively Modulates
Regulatory T Cell Suppressive Activity by Promoting
Degradation of the Transcription Factor Foxp3
Zuojia Chen,1,12 Joseph Barbi,2,12 Shurui Bu,2,3,12 Huang-Yu Yang,2,4 Zhiyuan Li,1 Yayi Gao,1 Dilini Jinasena,2 Juan Fu,2
Fang Lin,1 Chen Chen,1 Jing Zhang,1 Ning Yu,8 Xiangpei Li,8 Zhao Shan,1 Jia Nie,1 Zhimei Gao,1 Hong Tian,11
Yangyang Li,1 Zhengju Yao,1 Ying Zheng,2 Benjamin V. Park,2 Ziyi Pan,2 Jing Zhang,2 Eric Dang,2 Zhiguang Li,2
Honglin Wang,9 Weibo Luo,10 Liwu Li,11 Gregg L. Semenza,10 Song-Guo Zheng,5 Karin Loser,6 Andy Tsun,1
Mark I. Greene,7 Drew M. Pardoll,2 Fan Pan,2,* and Bin Li1,*
1Key Laboratory of Molecular Virology and Immunology, Unit of Molecular Immunology, Institut Pasteur of Shanghai, Shanghai Institutes for
Biological Sciences, Chinese Academy of Sciences, Shanghai 200025, China
2Immunology and Hematopoiesis Division, Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
University School of Medicine, Baltimore, MD 21287, USA
3Department of Gastroenterology, Affiliated Jinshan Hospital, Fudan University, Shanghai 201508, China
4Department of Nephrology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan 333, Taiwan
5Division of Rheumatology, Department of Medicine, Penn State University College of Medicine, Hershey, PA 17033, USA
6Department of Dermatology, University of Mu¨nster, D-48149 Mu¨nster, Germany
7Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadephia, PA 19104, USA
8Department of Rheumatology and Immunology, Affiliated Anhui Provincial Hospital, Anhui Medical University, Hefei 230001, China
9Shanghai Institute of Immunology, Institute ofMedical Sciences, Shanghai Jiao TongUniversity School ofMedicine, Shanghai 200025, China
10Departments of Pediatrics, Medicine, Oncology, Radiation Oncology, and Biological Chemistry, Johns Hopkins University School of
Medicine, Baltimore, MD 21205, USA
11Department of Biological Sciences, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA
12These authors contributed equally to this work
*Correspondence: fpan1@jhmi.edu (F.P.), binli@sibs.ac.cn (B.L.)
http://dx.doi.org/10.1016/j.immuni.2013.08.006SUMMARY
Regulatory T (Treg) cells suppress inflammatory im-
mune responses and autoimmunity caused by self-
reactive T cells. The key Treg cell transcription factor
Foxp3 is downregulated during inflammation to allow
for the acquisition of effector T cell-like functions.
Here, we demonstrate that stress signals elicited by
proinflammatory cytokines and lipopolysaccharides
lead to the degradation of Foxp3 through the action
of the E3 ubiquitin ligase Stub1. Stub1 interacted
with Foxp3 to promote its K48-linked polyubiqui-
tination in an Hsp70-dependentmanner. Knockdown
of endogenous Stub1 or Hsp70 prevented Foxp3
degradation. Furthermore, the overexpression of
Stub1 in Treg cells abrogated their ability to suppress
inflammatory immune responses in vitro and in vivo
and conferred a T-helper-1-cell-like phenotype. Our
results demonstrate the critical role of the stress-
activated Stub1-Hsp70 complex in promoting Treg
cell inactivation, thus providing a potential therapeu-
tic target for the intervention against autoimmune
disease, infection, and cancer.
INTRODUCTION
During inflammation, several types of physiological stresses
are likely to be encountered within the microenvironment. Such272 Immunity 39, 272–285, August 22, 2013 ª2013 Elsevier Inc.stressors include hypoxia, oxidative stress, microbial products
(e.g., lipopolysaccharide [LPS]), and inflammatory cytokines.
The notion that such stresses, or "danger signals," can regulate
immune responses has long been proposed (Shi et al., 2003).
Although intensive studies have demonstrated how such
stimuli can activate cells of the innate immune system—mainly
through innate receptors such as Toll-like receptors (TLRs) and
the inflammasome (Schroder and Tschopp, 2010), few studies
have addressed how stress signals inactivate the negative regu-
lators of the adaptive immune system, namely regulatory T (Treg)
cells, in order to facilitate effective immune responses (Gallucci
and Matzinger, 2001; Matzinger, 2007). Understanding the
impact of inflammatory stimuli on the Treg cell lineage is crucial
given the importance of these cells in mitigating excessive or
misdirected immune activation.
Treg cells can lose Foxp3 expression to gain effector T cell
function under inflammation, but how the stability of Foxp3
expression and the functional plasticity of the Treg cell lineage
are dynamically regulated are currently under debate (Miyao
et al., 2012; Rubtsov et al., 2010; Sakaguchi et al., 2013; Zhou
et al., 2009). The tissue microenvironment and inflammatory
milieumight play a role in the acquisition of T effector-like pheno-
types by Foxp3+ T cells (Floess et al., 2007; Fontenot et al.,
2005). Furthermore, cytokines such as IL-4, IL-6, and IL-21
have been shown to bestow Foxp3+ T cells with phenotypes of
various T effector subsets in vitro (Tsuji et al., 2009; Xu et al.,
2007; Yang et al., 2008). However, the mechanism underlying
Foxp3 degradation during inflammation remains unclear.
We investigated the impact of inflammatory stress on Treg
cell stability and function. We find that a mechanism regulating
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Treg and T effector cell activity. The downregulation of Foxp3,
and subsequent relief from Treg-cell-mediated immune sup-
pression in response to inflammatory cues, was dependent
on the ubiquitination of Foxp3 by the E3 ligase Stub1. The
interaction between Stub1 and Foxp3 was in turn dependent
on the stress-indicator protein Hsp70. These findings reveal
a hitherto unknown pathway for the reduction of Foxp3 protein
expression and loss of Treg-cell-mediated immune suppres-
sion in the face of inflammatory stimuli, and have implications
for a variety of diseases resulting from uncontrolled immune
responses.
RESULTS
Foxp3 Expression Is Destabilized by
Inflammation-Associated Stress Signals
The majority of natural Treg (nTreg) cells are relatively stable in a
healthy individual (Floess et al., 2007; Gavin et al., 2007). Howev-
er, 10%–15% of these "stable" Treg cells were found to lose
Foxp3 expression after their adoptive transfer into lymphopenic
hosts, while gaining the capacity to produce IL-2 and IFN-g.
Several groups have observed the loss of Foxp3 expression
during autoimmune inflammation through Foxp3 intracellular
staining or Foxp3-GFP reporter mice (Fontenot et al., 2005), sug-
gesting that under certain conditions Foxp3 expression and Treg
cell function might be unstable. We set out to determine whether
LPS or inflammatory cytokines—the stresses likely encountered
as a consequence of infection and inflammation—could nega-
tively affect Foxp3 protein stability at the posttranslational level.
To test this, we engineered a Jurkat T cell line stably expressing
HA-tagged Foxp3 under control of the constitutive ubiquitin
promoter (HA-Foxp3 Jurkat T cells) and exposed these cells
to several stimuli typical of inflamed tissues. Foxp3 protein
expression was noticeably decreased upon exposure to LPS
(Figure 1A). The addition of the proteasome inhibitor MG132
prevented Foxp3 loss, suggesting that this process was protea-
some dependent. Similar results were observed in CD4+ CD25hi
CD127lo human primary nTreg cells (Figure 1B); we also found
that heat shock, IL-1b, and TNFa resulted in the loss of Foxp3
in mouse nTreg cells (Figure 1C), where IL-1b and TNFa-medi-
ated Foxp3 loss was also prevented by the addition of MG132
(Figure S1A). Because exposure to LPS resulted in pronounced
loss of Foxp3 protein, we further explored the effects of LPS on
the stability of the Foxp3 protein pool. To this end, we measured
amounts of the transcription factor in cycloheximide (CHX)-
treated human primary Treg cells activated in the presence or
absence of LPS. Foxp3 was reduced by exposure of Treg
cells to LPS (Figure 1D). Further calculation revealed that LPS
treatment markedly shortened the half-life of Foxp3 in these
cells as compared to mock-treated cells (Figure S1B). As
previously seen, administration of MG132 stabilized Foxp3
levels in these cells (Figure S1C). Further demonstrating the
negative impact of inflammatory cues on Foxp3 expression,
repeated administration of low doses of LPS to C57BL/6 mice
resulted in Foxp3 downregulation in vivo. The splenocytes of
mice given LPS (intraperitoneally) contained a lower percentage
of Foxp3+ CD4+ T cells than control mice injected with PBS
(Figure 1E).To confirm that LPS destabilizes the Foxp3 protein pool, we
tested Treg cells incapable of detecting LPS through the TLR
signaling pathway for resistance to LPS-mediated Foxp3 loss.
We stimulated nTreg cells from wild-type C57BL/6 mice with
LPS, which, as expected, resulted in Foxp3 downregulation. In
contrast, Foxp3 expression was stabilized in Treg cells isolated
from mice genetically deficient in Myd88 (Myd88/ mice)
despite LPS exposure (Figure 1F), suggesting that LPS-medi-
ated TLR signaling negatively impacts the stability of Foxp3.
Corroborating the negative effects of LPS on Foxp3 expression,
qRT-PCR analysis showed that exposure of nTreg cells to LPS
in vitro elevates the expression of genes, such as Il2 and Ifng,
that are normally suppressed by Foxp3. Equally noticeable
was the reduced expression of genes activated by Foxp3 and
associated with the Treg cell phenotype; such genes included
Ctla4, Tnfrsf18, and Il2ra, for example (Figure S1D). These results
support a model wherein Foxp3 expression and Treg cell
function are suppressed in response to an imminent threat or
inflammatory microenvironment.
Identification of Hsp70, a Recruiter of Stub1,
as a Subunit of the Foxp3 Complex
To understand the mechanism underlying Foxp3 degradation,
we purified Foxp3 and its associated binding partners (Foxp3
complex) from TAP-Foxp3-transfected HEK293T cells by using
a tandem-affinity purification approach (data not shown). We
subsequently used mass-spectrometry (MS) sequencing to
identify individual peptides of any Foxp3 binding partners (Fig-
ure S1E). We found that the sequences of nine peptides within
the identified Foxp3 protein complex corresponded to heat-
shock 70kDa protein 1A (also known as Hsp70 or HSPA1A)
(UniProtKB: P08107) (Figure S1F). Both Hsp70 and the related
Hsc70 are known to recruit a stress-activated E3 ubiquitin
ligase named Stub1 to proteins targeted for degradation (Ballin-
ger et al., 1999). Stub1 was found upregulated in mouse nTreg
cells under the same inflammatory stresses that had previously
been shown to result in Foxp3 downmodulation (Figure 1C).
Additionally, treatment of human Treg cells with LPS resulted
in progressive loss of Foxp3 protein coincidently with Stub1 up-
regulation (Figure S1G). The cytokine IL-18, like IL-1b and TNFa,
increased Stub1 expression in Treg cells, whereas the inhibitor
SB203580 and exposure to osmotic stress or hypoxic culture
conditions all failed to noticeably alter Stub1 expression (Fig-
ure S1H). The observation that HIF-1a was not required for
LPS-induced Foxp3 downmodulation in Treg cells (Figure S1I)
suggested that LPS-Stub1-induced Foxp3 depletion is distinct
from the process we previously observed under hypoxic stress
(Dang et al., 2011). These results suggest that Stub1 is specif-
ically induced in Treg cells by inflammatory signals that regulate
Foxp3 at the protein level.
The selective nature of Stub1 induction was further demon-
strated by the observation that although LPS, a potent activator
of Toll like receptor signaling, is an effective inducer of both
Foxp3 loss and Stub1 mRNA expression, agonists specific to
other TLRs failed to significantly upregulate Stub1 in human
nTreg cells (Figure S1J). An inability to upregulate Stub1 in
response to LPS might be responsible for the stabilization of
Foxp3 levels inMyd88/Tregcells. Indeed, LPS failed tochange
Stub1 expression in these cells, unlike wild-type Treg cellsImmunity 39, 272–285, August 22, 2013 ª2013 Elsevier Inc. 273
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Figure 1. Foxp3 Interacts with Stub1 and Is Degraded in a Proteasome-Dependent Manner upon Exposure to Inflammatory Cues
A Jurkat cell line stably expressing HA-Foxp3 (HA-Foxp3 Jurkat T cells) (A) or primary human (B, D) or mouse (C) Treg cells were stimulated with LPS or other
cytokines for the indicated time periods in the absence or presence of 5 mMMG132. Cells were harvested and subjected to protein blotting (A, B, C). Panels (A)–(C)
are representative blots. Numbers under the Foxp3 and Stub1 bands in (C) represent their relative density. (D) LPS decreased Foxp3 half-life in Treg cells. Human
Treg cells were treated with 5 mg/ml CHX in the absence or presence of LPS. Cells were harvested at the indicated times. Cell lysates were analyzed by
immunoblotting. (E) Exposure to a low dose of LPS downregulates Foxp3 in vivo. C57BL/6 mice were injected weekly intraperitoneally with either 100 ml PBS
or 0.5 mg/kg LPS (E. coli 0111B4) over a 4 week period. Total splenocytes were harvested and subjected to flow-cytometry analysis of CD4+Foxp3+ cells. The
percentages of CD4+Foxp3+ T cells within total splenocytes were quantified and compared. *p < 0.05. Error bars represent mean +/ SEM. (F) Myd88 deficiency
renders nTreg cells resistant to LPS-mediated Foxp3 loss. CD4+CD25hi T cells (nTreg cells) were purified by flow cytometry from age- and sex-matchedwild-type
andMyd88/ C57BL/6 mice and activated through CD3/CD28 in the presence or absence of LPS (1mg/ml). Foxp3 and Stub1 protein expression was assessed
at the indicated time points. (G) HA-Foxp3 and Myc-Stub1 expression plasmids were cotransfected into 293T cells. Cells were lysed for coimmunoprecipitation
(co-IP) as indicated. (H) Naive T cells were isolated and cultured under iTreg-skewing conditions for 3 days, and this was followed by heat shock for 45min before
cells were harvested for endogenous co-IP and protein blotting, as indicated. Also see Figure S1.
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Stress-Activated Stub1-Hsp70 Degrades Foxp3(Figure 1F), suggesting that Stub1might be involved in the deple-
tion of Foxp3 from Treg cells under specific inflammatory condi-
tions and prompting us to test whether Stub1 could interact with
Foxp3 to mediate its degradation. 293T cells were cotransfected
with tagged Foxp3 or Stub1 expression constructs for immu-
noprecipitation (IP) studies. Foxp3 (HA-Foxp3) pulled down
Stub1 (Myc-Stub1), and Foxp3 was reciprocally pulled down
by Stub1 (Figure 1G). The interaction between endogenous
Stub1 and Foxp3 was further confirmed in induced Treg (iTreg)
cells derived in vitro from naive CD4+ T cells (Figure 1H).
Next, we further characterized the interaction between Foxp3
and Stub1. Through the generation of systematic deletion mu-
tants (Figure S1K) and cotransfection and co-IP experiments,
we found that both the leucine zipper and coiled-coil subdo-
mains of Foxp3 were essential for its interaction with Stub1;
deletion of either the zipper (C1 and N3) or coiled-coil (N2 and
N3) regions disrupted their interaction (Figure S1L). Additionally,
we found that Stub1 could translocate into the nucleus and
interact with Foxp3 under inflammation-associated stimuli (Fig-
ure S1M). Without LPS stimulation, Foxp3 mainly localized in
the nucleus, and Stub1 was in the cytoplasm (Figure S1M, left
panels). Adding the proteosome inhibitor MG132 to prevent
the loss of Foxp3 allowed for the visualization of Foxp3, which
colocalized with Stub1 after LPS stimulation, supporting the
notion that these factors might interact (Figure S1M). The trans-
location of Stub1 from the cytoplasm to the nucleus after LPS
treatment suggests that Stub1 translocation is a physiologically
relevant consequence of exposing Treg cells to inflammatory
stress and that Stub1-mediated loss of Foxp3 is both inducible
and spatially regulated during inflammation.
Stub1 Mediates the Ubiquitination and Degradation
of Foxp3
Because Foxp3 interacts with Stub1, which is known to degrade
transcription factors such as Runx2 (Li et al., 2008), we asked
whether Stub1 could directly ubiquitinate Foxp3 for degradation.
To test this, we cotransfected Flag-tagged Foxp3 or Foxp1
expression plasmids with HA-ubiquitin (HA-Ubi) and Myc-
Stub1 into 293T cells, then immunoprecipitated the ubiquitinated
proteins with anti-HA and performed immunoblotting with
anti-Flag antibody to detect ubiquitinated Foxp proteins. Stub1
promoted the ubiquitination of Foxp3, but not its subfamily
member Foxp1 (Figure 2A), which shares high homology at
the Zinc-finger leucine zipper and forkhead domain but not
the N-terminal subdomains. Stub1-mediated ubiquitination of
Foxp3 was further confirmed in Jurkat T cells (Figure 2B), which
were cotransfected with HA-Foxp3, Myc-Stub1, and Flag-Ubi
expression plasmids. As expected, Foxp3 polyubiquitination
was significantly enhanced upon the addition of Stub1 (Figures
2A and 2B). Also, Foxp3 polyubiquitination was enhanced in
iTreg cells overexpressing Stub1 (Figure S2A), and importantly,
Foxp3 ubiquitination was also detected in primary mouse nTreg
cells exposed to LPS (Figure 2C).
We next determined whether Stub1 is indeed required for the
LPS-induced loss of Foxp3 protein. A dose-dependent effect of
Stub1 on Foxp3 expression was observed in 293T cells cotrans-
fected with HA-Foxp3 and various doses of Myc-Stub1 plasmid.
When these cells were treated with DMSO, a Stub1-dose-
dependent, stepwise disappearance of Foxp3 protein wasseen. The addition of MG132 resulted in stable Foxp3 protein
expression even in the face of abundant Stub1 expression (Fig-
ure S2B). We then assessed the stability of Foxp3 expression in
the presence or absence of Stub1. To this end, we knocked
down Stub1 in HA-Foxp3-Jurkat T cells and monitored the
half-life of HA-Foxp3 in these cells and those carrying an sh-
control construct. Halting protein synthesis by CHX treatment
of sh-control HA-Foxp3-Jurkat T cells resulted in progressive
Foxp3 protein loss (Figure 2D). However, in agreement with
earlier observations, inhibiting the proteasome with MG132
preserved Foxp3 protein amounts throughout the experiment
(data not shown). Importantly, knocking down Stub1 in the pres-
ence of CHX similarly extended the half-life of Foxp3 (Figure 2D),
supporting a role for the E3 ligase in the depletion of cellular
Foxp3 pools. These results suggest that targeting Stub1 can
stabilize Foxp3 expression in the face of inflammatory stimuli.
Indeed, shRNA knockdown of Stub1 prevented LPS-mediated
Foxp3 loss in primary human nTreg cells, confirming its impor-
tance in this process (Figure 2E).
To test whether the E3 ligase activity and chaperone binding
ability of Stub1 are essential for promoting the ubiquitination of
Foxp3, we cotransfected 293T cells with HA-Foxp3, Flag-Ubi,
and either Myc-Stub1 or mutant Stub1 deficient in chaperone-
binding (K30A) or enzymatic activity (H260Q). We immunopre-
cipitated ubiquitinated proteins with anti-Flag antibody, then
performed immunoblotting with anti-HA antibody to detect
ubiquitinated Foxp3. We found that both the H260Q and K30A
mutants failed to promote the polyubiquitination of Foxp3
(Figure 2F), which suggests that the enzymatic activity and
chaperone-binding abilities of Stub1 are required for Foxp3
ubiquitination. Moreover, Stub1-mediated Foxp3 ubiquitination
occurred via K48 linkage given that the K48R mutant abrogated
this process (Figure 2G). These results suggest that Stub1 medi-
ates Foxp3 degradation through ubiquitination and the fact that
the proteasome in T cells encounters physiological danger sig-
nals. To further investigate Stub1-mediated ubiquitination and
degradation of Foxp3, we tested whether the elimination of
potential ubiquitination sites on Foxp3 could prevent Foxp3
removal by Stub1. Foxp3 constructs with mutated lysine resi-
dues were screened for resistance to Stub1-mediated degrada-
tion (Figure S3A). Suggesting that ubiquitination is key for Foxp3
downregulation, we found that altering all 20 lysine residues
(K-to-R mutations) prevented the depletion of Foxp3 by over-
expressed Stub1 (Figures S3A and S3B). Although many of the
individual lysine mutations did not stabilize Foxp3 protein levels,
a mutant altered at four lysine residues (K227R, K250R, K263R,
and K268R; thismutant is termed "4R") proved highly resistant to
degradation (Figure S3B).
These Stub1-resistant mutants were expected to be less
readily ubiquitinated thanwild-type Foxp3. To test this, we trans-
fected 293T cells with Flag-Foxp3, the 20R mutant (in which all
20 lysine residues in Foxp3 have been changed to arginine), or
the 4Rmutant, together withMyc-Stub1 and HA-Ubi. Forty-eight
hours later, we immunoprecipitated cell lysates by using anti-
Flag antibody and analyzed them by blotting for HA, Flag,
or Myc. We found that although wild-type Foxp3 was highly
ubiquitinated in the presence of Stub1, the 20R and 4R mutants
were not (Figure 3A). Interestingly, these Foxp3 mutants
retained their ability to interact with Stub1 despite resistingImmunity 39, 272–285, August 22, 2013 ª2013 Elsevier Inc. 275
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Figure 2. Stub1 Mediates Foxp3 Degradation through a Ubiquitination and Proteasome-Dependent Pathway
(A) Flag-Foxp3 or Flag-Foxp1 was cotransfected with Myc-Stub1 and HA-Ubi into 293T cells. Cells were lysed for co-IP as indicated.
(B) HA-Foxp3, Myc-Stub1, and Flag-Ubi were cotransfected into Jurkat T cells. The cells were processed for co-IP as indicated.
(C) Primary Treg cells were stimulated with LPS for 24 hr. Cells were then harvested and lysed, and co-IP was performed as indicated.
(D and E) HA-Foxp3 Jurkat cells were transduced with lentivirus carrying the control shCK or shStub1 constructs, and either CHX treatment followed for the
indicated periods (D) or human Treg cells transduced with shCK or shStub1 were treated by LPS for 24 hr (E) before cells were harvested for protein blotting as
indicated.
(F) HA-Foxp3, Flag-Ubi, and Myc-Stub1 or one of its mutants, K30A or H260Q, were cotransfected into 293T cells. The cells were lysed for co-IP as indicated.
(G) 293T cells were transfectedwith HA-Foxp3 andMyc-Stub1 together with Flag-Ubi (WT) or the ubiquitinmutant K48R or K63R. The cells were lysed for co-IP as
indicated. All panels are representative of at least three experiments. Also see Figure S2.
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Stress-Activated Stub1-Hsp70 Degrades Foxp3ubiquitination (Figure 3B). These findings support the notion that
Stub1 mediates Foxp3 degradation through ubiquitination at
key lysine residues.276 Immunity 39, 272–285, August 22, 2013 ª2013 Elsevier Inc.To investigate whether these Foxp3 mutants were also resis-
tant to degradation mediated by inflammatory stress, we stimu-
lated Jurkat T cells expressing wild-type Foxp3 or its 20R or 4R
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Figure 3. Two Foxp3 Mutants Lacking
Distinct Lysine Residues Interact with
Stub1 but Are Resistant to Stub1-Mediated
Ubiquitination
(A) 293T cells were transfected with Myc-Stub1,
HA-Ubi, and one of the following: Flag-Foxp3, the
20R mutant (20 lysine residues lost), or the K227/
250/263/268R (4R) mutant. Forty-eight hours after
transfection, the cells were harvested, and the cell
lysates were immunoprecipitated by anti-Flag
antibody prior to analysis by protein blotting for
HA, Flag, or Myc.
(B) 293T cells were transfected with Myc-Stub1
and one of the following: Flag-Foxp3, 20R mutant,
or K227/250/263/268R (4R) mutant. The cells
lysates were immunoprecipitated with anti-Myc
antibody and analyzed by protein blotting.
(C) Jurkat T cells expressing Foxp3 WT, the
20R mutant, or the 4R mutant were stimulated
with 1 mg/ml LPS for the indicated time periods.
The Foxp3 levels in cell lysates were analyzed by
protein blotting.
(D) nTreg cells were transduced with lentivirus
carrying Stub1-IRES-dsRed2 cassette; 48 hr after
transduction, dsRed2+ cells were sorted, retrans-
duced with lentivirus carrying empty vector, WT
Foxp3, or the 4Rmutant (all harboring GFPmarker
as an internal control), and cultured for another
2 days. The GFP+ cells were sorted and stimulated
for 24 hr before being harvested for immunoblot-
ting as indicated. Also see Figure S3.
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of the cell lysates revealed that, unlike wild-type Foxp3, which
was progressively lost, the 20R and 4R mutants were stably
expressed (Figure 3C). Furthermore, introducing the 4R Stub1-
resistant mutant into nTreg cells confirmed its enhanced
stability in the face of LPS treatment. Here, nTreg cells were
doubly transducedwith lentivirus carrying a Stub1-IRES-dsRed2
cassette containing empty vector, wild-type Foxp3, or the 4R
mutant (marked by GFP) prior to stimulation (Figure 3D). Collec-
tively, these results indicate that Foxp3 might be lost in Treg
cells in response to inflammatory danger signals that induce
ubiquitin conjugation by Stub1.
Hsp70 Is a Recruiter of Stub1 for the Ubiquitination
and Degradation of Foxp3
Because the biochemical stress indicator Hsp70 is required for
Stub1-mediated degradation of many proteins (Luo et al.,
2010), and given that Hsp70 was copurified with TAP-Foxp3
from ectopically expressed cell lines (Figures S1E and S1F),
we asked whether the Foxp3-Stub1 interaction was dependent
on Hsp70. To address this question, we cotransfected HA-
Foxp3 with Myc-Stub1 or its K30A or H260Q mutant intoImmunity 39, 272–285293T cells, immunoprecipitated Foxp3
with anti-HA antibody, and then per-
formed immunoblotting with anti-Myc
antibody. We found that both wild-type
and the H260Q Stub1 mutant interact
with Foxp3; however, the chaperone-
binding-deficient mutant K30A could notdo so (Figure 4A). The interaction between Hsp70 and Foxp3
was also demonstrated by endogenous co-IP in nTreg cells
(Figure 4B). These results suggest that Hsp70 might mediate
the interaction between Foxp3 and Stub1. Moreover, we found
that overexpression of both Stub1 and Hsp70 had a synergistic
effect on mediating Foxp3 degradation (Figure 4C). We also
found that the knockdown of Hsp70 in Foxp3-Jurkat T cells
mitigated Stub1-mediated degradation of Foxp3 (Figure 4D).
To further verify the involvement of Hsp70 in Foxp3 ubiquiti-
nation and degradation by Stub1, we purified MBP, MBP-
Foxp3, His-E1, His-Ubc5Hb (E2), His-Stub1 (E3), His-Flag-Ubi,
and His-Hsp70 expressed in Escherichia coli for an in vitro
ubiquitination assay (Figure 4E). Hsp70 was essential for
Stub1-mediated ubiquitination of Foxp3 in this cell-free system
(Figure 4E). Interestingly, although both Hsp70 and the closely
related but non-inflammation-associated Hsc70 interact with
Foxp3 as assessed by co-IP (Figure S4A), we found that
overexpression of Hsp70 but not Hsc70 could promote Foxp3
ubiquitination and degradation (Figure S4B). These results
suggest that the stress indicator Hsp70, but not constitutively
expressed Hsc70, is an essential mediator of the Stub1-Foxp3
interaction., August 22, 2013 ª2013 Elsevier Inc. 277
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Figure 4. Stub1 Interacts with Hsp70 and Requires It for Degradation of Foxp3
(A) 293T cells were cotransfected with plasmids encoding HA-tagged Foxp3, together with either Myc-tagged wild-type Stub1 or its mutant (K30A or H260Q).
Foxp3 protein in the cell lysates was immunoprecipitated by anti-HA antibody, and pulled down Stub1 was detected by protein blotting.
(B) Primary Treg cells were sorted from IRES-GFP reporter mice and stimulated with LPS for 24 hr before being harvested for co-IP and immunoblotting as
indicated.
(C) HA-Foxp3, Myc-Stub1, and Flag-Hsp70 were co-transfected into 293T cells. Cell lysates were analyzed by protein blotting.
(D) HA-Foxp3 Jurkat T cells were transduced with lentivirus carrying the shCK control or with shHsp70 constructs carrying a puromycin selection marker.
Selected cells were treated with LPS for the indicated time periods before being harvested for protein blotting with the indicated antibodies.
(E) Purified 6His-E1, 6His-UbcH5b, 6His-Stub1, 6His-Flag-Ubi, 6His-Hsp70, and either MBP-Foxp3 or MBP were mixed together in a cell-free system and
incubated at 30C for 2 hr. Foxp3 ubiquitination was detected by protein blotting with an anti-MBP antibody. Depicted are the representative results of at least
three independent experiments. Also see Figure S4.
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Transcriptional Repression, and Treg Function inMouse
Primary T Cells
To further test the effects of overexpressing Hsp70 and Stub1 on
Foxp3-mediated suppressive activity, we transfected Jurkat
T cells with plasmids encoding Stub1, Foxp3, and/or Hsp70 in
various combinations along with a luciferase reporter construct
under the control of the Il2 promoter and measured luciferase
activity. As expected, Foxp3 expression suppressed promoter
activity. However, coexpression of Foxp3 with Stub1 resulted
in a near complete reversal of Il2 promoter suppression, a trend278 Immunity 39, 272–285, August 22, 2013 ª2013 Elsevier Inc.made more pronounced by simultaneous expression of Hsp70
(Figure S5A). Supporting results were also obtained via a lucif-
erase-based transcriptional repression assay (Li et al., 2007) in
293T cells (Figure S5B). Immunoblotting of the cells confirmed
that Foxp3 protein was nearly completely lost when cells
received both Stub1 and Hsp70 (Figure S5C), suggesting that
the loss of transcriptional suppression was indeed due to
Foxp3 loss. These findings also reinforce the need for coopera-
tion between Hsp70 and Stub1 for Foxp3 degradation.
Because Foxp3 is responsible for the suppression of IL-2
expression in primary T cells (Lopes et al., 2006; Zheng et al.,
Immunity
Stress-Activated Stub1-Hsp70 Degrades Foxp32007), we tested whether Stub1 was able to mitigate IL-2 sup-
pression by Foxp3 in T cells by using lentivirus-based delivery
of Stub1 into primary CD4+ T cells that were then transduced
with a bicistronic retroviral vector encoding full-length Foxp3.
As in Jurkat cells, the expression of Foxp3 almost completely
blocked IL-2 production in primary T cells. However, the co-
expression of Stub1 reversed Foxp3-mediated suppression of
IL-2 secretion (Figure 5A). Supporting the notion that Stub1
removes Foxp3 from the transcriptional regulatory landscape
by promoting its degradation, immunoblotting of these doubly
transduced cells confirmed that Stub1 overexpression coin-
cided with the reduction of Foxp3 protein amounts (Figure S5D).
These results suggest that within T cells, Stub1 negatively regu-
lates Foxp3-mediated transcriptional repression.
We next askedwhether Stub1 could negatively regulate Foxp3
in primary mouse nTreg cells. CD4+CD25hi T cells isolated from
C57BL/6mice were transduced with retrovirus containing empty
vector (carrying GFP as a marker) or a Stub1 expression
construct, and intracellular staining for Foxp3, IFN-g, and IL-2
followed. We observed that nTreg cells overexpressing Stub1
displayed reduced Foxp3 expression with increased production
of IL-2 and IFN-g (Figure 5B; see also Figures S5E and S5F),
suggesting a loss of characteristic Treg gene silencing in these
cells. Furthermore, we measured the expression of several
Treg- and T effector (Teff)-cell-associated genes. In agreement
with our earlier results, transcript levels of IL-2 and IFN-g were
elevated by Stub1 overexpression in nTreg cells. Additionally,
the expression of CD25, CTLA-4, GITR, and IL-10 was reduced
in comparison recipients of control vector (Figure S5G).
Stub1 also negatively impacts the function of Treg cells
in vitro. Unlike nTreg cells receiving the control vector, those
overexpressing Stub1 were markedly less capable of suppress-
ing the proliferation of naive CD4+ T cells in a carboxyfluorescein
succinimidyl ester (CFSE) dilution assay (Figure 5C). On the
other hand, shRNA knockdown of Stub1 improved the sup-
pression of naive T cell proliferation (Figure 5D). These findings
suggest that Stub1 in primary Treg cells results in poly-
ubiquitination-mediated degradation of Foxp3, loss of effector
gene silencing, acquisition of effector function, and loss of
Treg suppressive function.
Stub1 Overexpression in Treg Cells Eliminates Their
Ability to Suppress Pathologic Immune Responses
To verify our in vitro findings, we determined the impact of
Stub1 overexpression on the function of Treg cells in an in vivo
colitis model where severe Th1-cell-mediated inflammation
within the colon is induced after the transfer of naive CD4+
CD25 CD62Lhi T cells in the absence of Treg cells into Rag2/
recipient mice (Powrie et al., 1993). In this model, cotransfer of
CD4+ CD25+ nTreg cells with naive T cells is sufficient to prevent
the development of disease (Izcue et al., 2006). Wild-type or
lentiviral (LV) control modified Treg cells effectively suppressed
the development of disease as judged by both body weight
loss (Figure 6A) and histological analysis of tissue isolated from
the colon (Figure 6B). However, transfer of LV-Stub1-expressing
nTreg cells in the presence of CD4+CD25-CD62Lhi effector
T cells failed to prevent disease (Figures 6A–6C).
Additionally, we tracked the fate of injected Treg and naive
T cells (marked by congenicmarkers Thy1.1 and Thy1.2, respec-tively). Lymph node (LN), spleen (SPL), and gut lamina propria
(LP) infiltrating cells were recovered and stained for the indicated
surface markers as well as Foxp3, IL-2, and IFN-g, as described
previously (Dang et al., 2011). In all tissues sampled, the nTreg
cells overexpressing Stub1 displayed a marked reduction of
Foxp3 staining (Figure 6D, green line) compared to that of Treg
cells harboring the control vector (Figure 6D, blue line).
Commensurate with Foxp3 loss in Stub1-overexpressing Treg
cells, the cotransferred naive T cells recovered from these
mice produced more IL-2 than those recovered from the control
group (Figure 6E), indicative of a more robust and less restrained
T cell response. This was accompanied by severe disease,
evident in the histological data (Figures 6A–6C). A similar trend
was observed upon staining of the naive T cell population for
the proinflammatory cytokine IFN-g (Figure 6F), which further
suggests that the loss of Treg-cell-mediated suppression was
a consequence of forced Stub1 expression in these cells.
Also, analysis of the cytokine produced by the original Treg
cells revealed that Stub1-overexpressing cells not only lost
Foxp3 and the ability to suppress colitis but also took on a
Th1-cell-like phenotype wherein they, unlike Treg cells carrying
empty vector, produced considerable amounts of IFN-g
(Figure S6A).
Analysis of the frequency of transduced Treg cells (Thy1.1+)
among the cells infiltrating relevant tissues and their absolute
numbers was also informative with regard to the impact of
Stub1 on in vivo Treg function. Despite the fact that Stub1 over-
expressing Treg cells typically comprised a smaller percentage
of LN, SPL and LP cells compared to empty-vector controls
(a potential indication of inferior suppression of naive T cell pro-
liferation), the numbers of Stub1-overexpressing Treg cells were
either comparable to (LN, SPL) or greater (LP) than those of con-
trols (Figures S6B and S6C). These results suggest that forced
Stub1 expression in Treg cells does not hinder cell survival
during adoptive transfer in this experimental period but rather
suggest that it renders them less capable of restraining the
colitogenic response.
Silencing Stub1 Expression Enhances Treg-
Suppressive Function In Vitro and In Vivo
Because silencing Stub1 resulted in stabilized Foxp3 protein
levels in cell lines and primary nTreg cells, we suspected that
knocking down Stub1 in T cells might cause aberrant Foxp3
accumulation even under non-Treg-favoring conditions. As in
experiments described earlier, we introduced an sh-Stub1
construct or an sh-control into primary T cells by lentiviral trans-
duction. As expected, shRNA knockdown of Stub1 in naive
T cells under Th1- or Th17-cell-skewing culture conditions
increased Foxp3 expression in these cells as compared to con-
trols (modestly in Th1-cell-skewing conditions but markedly
in Th17-cell-skewing conditions). Additionally, upregulation of
IFN-g and IL-17 in these Th1 and Th17 skewed T cells was sup-
pressed in the absence of Stub1 (Figures S6D and S6E). Despite
this dramatic accumulation of Foxp3 protein seen upon Stub1
knockdown, the expression of Foxp3 transcript measured by
qRT-PCR did not change significantly (Figure S6F). These results
suggest that Stub1 is required for the prevention of Foxp3
upregulation during T helper development and that it therefore
might also play a relevant role in non-Treg cells. Activation ofImmunity 39, 272–285, August 22, 2013 ª2013 Elsevier Inc. 279
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Figure 5. Effects of Stub1 Overexpression or Knockdown on Foxp3-Mediated Gene Suppression In Vitro
(A) Primary mouse T cells were transduced with either lentivirus-based control vector (LV-ctrl) or LV-Stub1 expression plasmids carrying an IRES-GFP marker
for monitoring transduction efficiency. GFP+ cells were sorted, then transduced with either a biscistronic retroviral empty vector (carrying an IRES-dsRed2
marker) or the vector expressing full-length Foxp3. GFP+ dsRed2+ cells were sorted from each group and cultured in the presence of anti-CD3 plus anti-CD28
antibodies overnight. The supernatants were collected, and IL-2 production was determined by ELISA with samples run in triplicate. Results are represented
as means +/ SEM.
(B) Mouse primary nTreg cells (CD4+ CD25hi) were transduced with either lentivirus-based control vector (LV-ctrl) or LV-Stub1 expression plasmid carrying an
IRES-GFP marker for monitoring transduction efficiency. Cells were treated as in (A) prior to intracellular staining of Foxp3, IFN-g, and IL-2, then analyzed by
flow cytometry. Shown are representative histogram overlays from one of at least three trials depicting staining intensity of the indicated marker in transduced
cells (GFP+ cells). Red lines indicate the LV control; blue lines represent Stub1-overexpressing cells, and isotype controls are depicted in green.
(C and D) Thy1.1 marked naive CD4+ T cells were stained with CFSE and coincubated with irradiated APCs (CD3- splenocytes) with normal, Stub1-over-
expressing (C), or Stub1-silenced (D) Thy1.2+ Treg cells (obtained by retroviral transduction as mentioned above) at the indicated ratios. CFSE dilution was
determined for Thy1.1+ responder cells by flow cytometry. Data are representative of at least three independent experiments. Also see Figure S5.
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Stress-Activated Stub1-Hsp70 Degrades Foxp3naive T cells in the presence of IL-6 and other STAT3 signaling
cytokines will drive Th17 cell differentiation, and Treg cells acti-
vated in the presence of IL-6 downregulate Foxp3 and take on
effector cell characteristics. In order to determine whether these
conditions involve Stub1-mediated Foxp3 protein removal, we
activated human Treg cells in the presence of IL-6 andmeasured
the amount of both Foxp3 and Stub1 protein. We found that IL-6
in conjunction with TCR stimulation resulted in progressive
Foxp3 downregulation and Stub1 accumulation (Figure S6G).
We hypothesized that, in addition to accumulating Foxp3 pro-
tein, cells lacking Stub1 would possess enhanced expression
of Treg-cell-associated genes. In support of this, and in contrast
to the effects of Stub1 overexpression, when Stub1 is knocked
down in mouse nTreg cells, transcripts for CD25, CTLA-4,
GITR and IL-10 were increased over those seen in sh-controls
(Figure S6H). These results confirm a role for Stub1 in controlling
Foxp3 expression at the posttranscriptional level and also offer
potential mechanistic insights into the enhanced in vitro sup-
pression of Stub1-deficient Treg cells.
The impact of Stub1 knockdown on in vivo Treg cell function
was also studied in the colitis model mentioned earlier. As
before, Treg cells were cotransferred along with naive CD4+
T cells into lymphopenic recipient mice. However the ratio of
Treg cells to colitogenic naive T cells in the adoptive transfer
was lower (0.5 3 105:1 3 106 as opposed to 2 3 105:1 3 106).
In this approach, cotransfer of normal Treg cells will only partially
rescue recipient mice from colitis, and importantly, enhance-
ment of Treg cell suppression should be readily apparent. We
hypothesized that under these conditions recipients of sh-
Stub1-treated nTreg cells will be more protected than recipients
of sh-control-treated Treg cells. Indeed, Treg cells carrying
Stub1-targeting shRNA largely protected recipients from colitis
and yielded weight-change curves resembling those of mice
receiving no colitogenic naive T cells. Cotransfer of wild-type
or sh-control-carrying nTreg cells with naive T cells, on the other
hand, afforded only a partial reduction in disease severity (Fig-
ure 6G). Histological scoring of stained tissue sections echoed
these results (Figure 6H). In all, these results reinforce the con-
clusions drawn from our in vitro assays and support the notion
that Stub1, an E3 ligase capable of interacting with the chap-
erone Hsp70 and its target Foxp3, is a key regulator of Treg
cell identity and function during inflammation.
DISCUSSION
Tight control over the intensity and timing of an immune
response is necessary to defend the host from invading patho-
gens while sparing host tissues from unnecessary immunopa-
thology. Suppressor cells such as Foxp3-expressing Treg cells
provide a level of immune regulation by promoting tolerance
and dampening immune activation. However, during acute infec-
tion, the function of Foxp3+ Treg cells in an inflammatory site
may be temporarily neutralized, permitting immune activation
adequate to fight infection. In this scenario, a rapid mechanism
for downmodulating Treg cell function is important for host
defense. Although many recent studies have focused heavily
on how Foxp3 is induced in Treg cells, much less attention has
been paid to how Foxp3 protein is negatively regulated and to
the consequences for suppressive function. In the presentwork we explored how posttranslational modification of Foxp3
might serve as a Treg cell "off switch," negatively regulating
Foxp3 stability and activity during inflammation. Here, we report
that the E3 ligase Stub1, which is known to be expressed in
response to danger signals during inflammation (Connell et al.,
2001; Dai et al., 2003), is responsible for ubiquitinating Foxp3
with the help of the chaperone Hsp70 in a process that leads
to the degradation of the chief Treg cell transcription factor.
There existed reasons to suspect an immunomodulatory role
for elements of the inflamed microenvironment. We have
recently found a role for elements of the hypoxia response
(HIF-1a) in tipping the balance between opposing T cell subsets
(Dang et al., 2011) by specifically promoting Th17 differentiation
at the expense of Foxp3 expression and Treg cell generation.
However, hypoxia is not the only aspect of inflamed or infected
tissues to affect immune responses. The impact of microbial
products and proinflammatory cytokines on the immune
response has been studied in great detail (Kawai and Akira,
2007), as have the effects of oxidative stresses (Mougiakakos
et al., 2011). It is not surprising that Treg cell behavior responds
to these stimuli as well. The HSPs act as important molecular
chaperones, but in addition to regulating protein homeostasis
during the heat shock response, they are also involved in
bolstering immune responses under various stress conditions,
including fever, oxidative stress, and inflammatory cytokine
signaling during viral infection. In response to stress signals
such as these, HSPs are thought to mediate both constitutive
and inducible danger signals that activate immune responses.
In the immune system, HSPs, such as Hsp60 and Hsp70, have
been recently reported to activate the innate immune system
(Gallucci and Matzinger, 2001; Matzinger, 2007). It is possible
that Hsp70, by recruiting Stub1 under stress conditions, also
allows rapid unleashing of the immune system by undermining
the Foxp3 protein pool.
In this study we found that Foxp3 can be downregulated in
Treg cells by danger signals such as LPS and proinflammatory
cytokines. It should be noted, however, that a prior study re-
ported LPS-mediated enhancement of the Treg cell population
and its suppressive function (Caramalho et al., 2003). However,
that study did not assess Foxp3 expression, and it is difficult to
discern the expected tolerogenic effects of LPS as mediated
through antigen-presentation cells (APCs) from its direct results
on Foxp3 protein. Interestingly, however, LPS was shown to
increase effector cytokine production by Treg cells (Milkova
et al., 2010)—an observation compatible with ours. Although
purified Treg cells have shown an increase in Foxp3 mRNA
upon treatment with both LPS and IL-2, a sizable increase in
the amount of Foxp3 protein was not seen (Milkova et al.,
2010). These results could reflect opposing processes that
regulate transcript and protein pools and that might be respon-
sive to distinct inputs. Here we provide evidence that the direct
effects of LPS, and potentially other inflammation cues, on
Treg cells have a unique outcome: namely, the downregulation
of Foxp3 at the posttranslational level through the E3 ubiquitin
ligase activity of Stub1. The resulting suspension of Treg cell
function is likely to enhance the amplitude of an immune system
in order to overcome an infectious threat. It is tempting to spec-
ulate that the well-documented tolerogenic effects of LPS on
APCs (Bryn et al., 2008; Maldonado and von Andrian, 2010;Immunity 39, 272–285, August 22, 2013 ª2013 Elsevier Inc. 281
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Stress-Activated Stub1-Hsp70 Degrades Foxp3Tattevin et al., 2010) and their ability to expand or induce Treg
cells represent a compensatory mechanism for restoration of
the Foxp3+ cell pool and the prevention of widespread loss of
immune regulation.
Our previous study has shown that Foxp3 is subject to ubiq-
uitination (Dang et al., 2011). However, the enzyme responsible
for the modification of Foxp3 remains unknown. Our findings
reveal a mechanism for Foxp3 regulation at the posttransla-
tional level. They also further the notion, forwarded by several
groups, that there exists a plastic Treg cell lineage capable of
suppressing or permitting (or perhaps even contributing to)
immune responses. Previously, potential mechanisms for a
loss of Foxp3 expression involved the transcription level.
Specifically, the methylation state of distinct regions of the
Foxp3 gene contributes to the stability or relative instability of
Treg cells. For instance, repeated in vitro activation of human
Treg cells results in CpG-island methylation within a conserved
region of the Foxp3 gene in CD4+ CD25+ CD127lo T cells
and leads to the loss of Foxp3 expression and acquisition of
effector cytokine production (Hoffmann et al., 2009). Con-
versely, inhibition of DNA methylation results in Foxp3 ex-
pression even in CD25 conventional T cells, and the cytokine
TGF-b enforces a nonmethylated state of this conserved
regulatory region (Nagar et al., 2008). Additionally, inhibition
of DNA methylation in vivo was noted to increase the number
of Treg cells and to enhance suppression of diabetes in mice
(Zheng et al., 2009), suggesting that modulating the stability
of Treg cells has physiological consequences in the disease
setting.
These findings have expanded our understanding of Treg cells
and the dynamic nature of their participation in the immune
response. Adding another layer of complexity to the subject,
we show a key molecular mechanism for the regulation of
Foxp3 at the protein level; this mechanism integrates physiolog-
ical cues from the microenvironment. This ubiquitination-depen-
dent pathway probably plays a role in the newly appreciated
potential for Treg cells to regulate the immune response in
ways other than suppression (i.e., by swapping inhibitory func-
tion for effector function). Importantly, given that we have shown
ubiquitination-mediated removal of Foxp3 protein modulates
Treg cell function, it stands to reason that the enzymatic inhibi-
tion of such a process should have opposing effects. BecauseFigure 6. Stub1 Overexpression Renders Treg Cells Incapable of Supp
Naive CD4+ T cells (1 3 106 ) (CD62Lhi CD25) alone were injected intravenously
(A) Mice were monitored weekly for weight loss. Shown are mean percentages
experiments (n = 10 per group).
(B) Representative photomicrography of the distal colon ofRag2/mice after T ce
standard H&E staining and histological analysis. (i)–(iv) present bright-field micro
(C) H&E slides were scored in a blinded fashion, and colon pathology was scored
SD from at least three independent experiments.
(D) Foxp3 expression by transferred Treg cells carrying control vector (blue) or Stu
indicated tissues and staining was performed for surface markers and intracellul
gated on CD4+Thy1.1+ events (original Treg cells).
(E and F) Intracellular IL-2 and IFN-g levels in cotransferred CD4+ Thy1.2+ cells w
experiments.
(G andH) As above, colitis was induced, but lower ratios of Treg:Tnaive cells were
in combination with WT Tregs or received Treg cells transduced with either contro
H&E-stained sections were scored as mentioned previously. Shown are the mean
least two experiments. Also see Figure S6.this indeed appears to be the case (van Loosdregt et al.,
2013), ubiquitination-disrupting therapies deserve vetting as
interventions for autoimmune disease.
Here we have revealed the degradation of Foxp3 by Hsp70-
mediated recruitment of Stub1 as a mechanism responsible for
the observed instability of Foxp3+ Treg cells. Besides the induc-
ible expression of Hsp70 as an adaptor between Foxp3 and
Stub1, the spatial and temporal regulation of Stub1 expression
and activity during T cell differentiation deserves further atten-
tion. Additionally, the long-term fate of Stub1-expressing Treg
cells should be studied further in physiological settings. These
cells might regain Foxp3 and Treg function upon removal of
Stub1-inducing stresses or continue to display characteristics
of effector cells. Because Foxp3+ Treg cells that are capable of
IFN-g expression and that have reduced immune suppressive
activity can be found in human MS patients (Dominguez-Villar
et al., 2011), it is possible that factors such as Stub1 that drive
acquisition of T-cell-effector-like phenotypes in Treg cells are
at play in human autoimmune diseases. Although many aspects
of Treg cell instability remain unclear, our findings contribute to
the understanding of Foxp3 expression and function.
The importance of transcriptional, and specifically epigenetic,
control of Foxp3 has been demonstrated by numerous groups
of late. This level of regulation is now known to be important
for determining the relative stability or instability of Treg cells
(Ohkura et al., 2013). In this work we show a posttranslational
mechanism for negative regulation of Foxp3 by Stub1-influ-
encing Treg cell function. Our findings could have exciting ther-
apeutic implications for human diseases. In chronic infection,
Treg cells have been shown to prevent sterile clearance, result-
ing in small numbers of organisms that are latently present and
capable of reactivation (Belkaid et al., 2002). Treg cells are
known to limit anti-tumor responses and allow the persistence
and growth of cancer (Nishikawa and Sakaguchi, 2010). Tempo-
rary release from the suppressive influence of Treg cells or
conversion of these cells into active participants in the inflam-
matory immune response might prove beneficial to individuals
suffering from such diseases. Conversely, many autoimmune
diseases arise from Treg cell deficits, and targeting the machi-
nery responsible for Foxp3 loss, such as the Hsp70/Stub1
degradation axis, could yield successful therapies for numerous
diseases stemming from inadequate immune restraint.ressing Colitis in Rag2–/– Mice
into Rag2/ mice, or they were mixed with the indicated Treg cells (2 3 105).
of initial body weight (+/ SEM) for each group observed over at least three
ll transfer. Eight weeks after transfer, colons were harvested and processed for
graphs (1003).
as described previously. Shown are mean scores for each treatment group +/
b1 expression vector (green) was determined after cells were isolated from the
ar Foxp3. Staining controls are in red. Depicted are representative histograms
ere assessed as above. Shown are representative dot plots from at least two
used (0.53 105:13 106). (G)Rag2/mice either received naive T cells alone or
l vector or sh-Stub1 constructs, and the weight of the mice was monitored. (H)
percentages of starting mouse weights and histology scores +/ SEM from at
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Mice
All animal experiments were performed in the specific-pathogen-free facilities
of the Johns Hopkins Animal Resource Center with the approval of the Johns
Hopkins Animal Care and Use Committee and in accordance with national,
state, and institutional guidelines.
Human Primary cells
Human primary cells were purified from peripheral blood mononuclear cells
of healthy donors at the Shanghai Blood Center with a fluorescence activated
cell sorting (FACS) ARIA II cell sorter (BD Biosciences). The assay for cell
stimulation was performed as described in Supplemental Information.
Quantitative Real-Time PCR
Total RNA was isolated with the QIAGEN miniRNA extraction kit according
to the manufacturer’s instructions. RNA was quantified and complementary
DNA was reverse transcribed with the cDNA archive kit (Applied Biosystem)
according to the manufacturer’s instructions. PCR reactions were run in
an ABI Prism 7500 Sequence Detection System. Quantification of relative
mRNA expression was determined by the comparative CT method; normali-
zation was to endogenous b-actin or 18 s rRNA expression.
Cells, Virus, and Transfection
Virus-containing supernatants were obtained from human HEK293T cells
transfected with the indicated plasmids via lipofectamine 2000 reagent
(Invitrogen) according to the manufacturer’s instructions.
For Stub1 overexpression or knockdown experiments, primary Treg cells
(CD25hi/CD4+) were purified by FACS and transduced with the pLV-Stub1 or
pLV-shStub1 vector or with a control vector encoding either GFP alone or a
scrambled shRNA control (where appropriate). GFP signal was used as an
indicator of successful transfection or transduction.
Luciferase Assay
Luciferase promoter assays were performed as described previously
(Li et al., 2007).
Immunoblotting and Immunoprecipitation
Immunoblotting and immunoprecipitation were performed as described in
the Supplemental Experimental Procedures.
Colitis Induction and Histological Assessment
Naive CD4+ CD25 CD62Lhi T cells were isolated from BALB/c mice and
injected via the tail vein into BALB/c RAG2/ immunodeficient recipients
(13 106/mouse). BALB/c wild-type CD4+ CD25+ Treg cells, Stub1-transduced
Treg cells, or Treg cells receiving sh-Stub1 constructs, sh-control constructs,
or an empty vector were coinjected intravenously, as indicated. In all experi-
ments, mouse weights were monitored weekly, and tissues were removed
8 weeks after transfer, processed, and scored as described previously
(Pan et al., 2009 and Supplemental Experimental Procedures). Leukocytes
recovered from recipient lymph node, spleen, and lamina propria were isolated
and restimulated as previously described before surface staining for CD4,
Thy1.1, and Thy1.2 and intracellular staining for Foxp3, IL-2, and IFN-g were
performed.
Statistical Analysis
The significance of differences, unless otherwise indicated, was determined
by an unpaired Student’s t test, and a p value less than 0.02 was considered
significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures can be found with this article online at http://dx.doi.org/
10.1016/j.immuni.2013.08.006.284 Immunity 39, 272–285, August 22, 2013 ª2013 Elsevier Inc.ACKNOWLEDGMENTS
We thank P. Coffer and J. van Loosdregt for helpful discussions. Our research
is supported by National Natural Science Foundation of China grants
30972702, 31170825, 31200647, 31200646, 81271835, 81270083,
31150110337, and 81161120417; National Science and Technology Major
Project 2012ZX10002007-003, 2013ZX10003009-002; and the NN-CAS
Foundation. B.L. is supported by the Shanghai Science and Technology
‘‘Rising Star’’ Program (10QA1407900) and CAS ‘‘100-talent’’ program. S.Z.
is a Tina C. Foundation Lupus Research Award winner. We gratefully acknow-
ledge the support of the SA-SIBS scholarship program and the Knowledge
Innovation Program of the Shanghai Institute for Biological Sciences, Chinese
Academy of Sciences (2012KIP204). We thank X. Cao and Y.-J. Liu for their
critical reading for the manuscript. We thank the members of the Pan and
Pardoll Labs for helpful discussions. F.P. is a Stewart Trust Scholar and
Melanoma Research Alliance Young Investigator Award winner. F.P.’s labo-
ratory is partially supported by grants from the National Institutes of Health
(RO1AI099300 and RO1AI089830), ‘‘Kelly’s Dream’’ Foundation, the Janey
Fund, and the Seraph Foundation, and gifts from Bill and Betty Topecer and
Dorothy Needle. J.B. is supported by a Crohn’s and Colitis Foundation of
America Research Fellowship.
Received: May 4, 2012
Accepted: May 31, 2013
Published: August 22, 2013REFERENCES
Ballinger, C.A., Connell, P., Wu, Y., Hu, Z., Thompson, L.J., Yin, L.Y., and
Patterson, C. (1999). Identification of CHIP, a novel tetratricopeptide repeat-
containing protein that interacts with heat shock proteins and negatively reg-
ulates chaperone functions. Mol. Cell. Biol. 19, 4535–4545.
Belkaid, Y., Piccirillo, C.A., Mendez, S., Shevach, E.M., and Sacks, D.L. (2002).
CD4+CD25+ regulatory T cells control Leishmania major persistence and im-
munity. Nature 420, 502–507.
Bryn, T., Yaqub, S., Mahic, M., Henjum, K., Aandahl, E.M., and Taske´n, K.
(2008). LPS-activated monocytes suppress T-cell immune responses and
induce FOXP3+ T cells through a COX-2-PGE2-dependent mechanism. Int.
Immunol. 20, 235–245.
Caramalho, I., Lopes-Carvalho, T., Ostler, D., Zelenay, S., Haury, M., and
Demengeot, J. (2003). Regulatory T cells selectively express toll-like
receptors and are activated by lipopolysaccharide. J. Exp. Med. 197,
403–411.
Connell, P., Ballinger, C.A., Jiang, J., Wu, Y., Thompson, L.J., Ho¨hfeld, J., and
Patterson, C. (2001). The co-chaperone CHIP regulates protein triage deci-
sions mediated by heat-shock proteins. Nat. Cell Biol. 3, 93–96.
Dai, Q., Zhang, C., Wu, Y., McDonough, H., Whaley, R.A., Godfrey, V., Li, H.H.,
Madamanchi, N., Xu, W., Neckers, L., et al. (2003). CHIP activates HSF1 and
confers protection against apoptosis and cellular stress. EMBO J. 22, 5446–
5458.
Dang, E.V., Barbi, J., Yang, H.Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z.,
Fu, J., Kim, Y., Yen, H.R., et al. (2011). Control of T(H)17/T(reg) balance by
hypoxia-inducible factor 1. Cell 146, 772–784.
Dominguez-Villar, M., Baecher-Allan, C.M., and Hafler, D.A. (2011).
Identification of T helper type 1-like, Foxp3+ regulatory T cells in human auto-
immune disease. Nat. Med. 17, 673–675.
Floess, S., Freyer, J., Siewert, C., Baron, U., Olek, S., Polansky, J., Schlawe,
K., Chang, H.D., Bopp, T., Schmitt, E., et al. (2007). Epigenetic control of the
foxp3 locus in regulatory T cells. PLoS Biol. 5, e38.
Fontenot, J.D., Rasmussen, J.P., Williams, L.M., Dooley, J.L., Farr, A.G., and
Rudensky, A.Y. (2005). Regulatory T cell lineage specification by the forkhead
transcription factor foxp3. Immunity 22, 329–341.
Gallucci, S., and Matzinger, P. (2001). Danger signals: SOS to the immune
system. Curr. Opin. Immunol. 13, 114–119.
Immunity
Stress-Activated Stub1-Hsp70 Degrades Foxp3Gavin, M.A., Rasmussen, J.P., Fontenot, J.D., Vasta, V., Manganiello, V.C.,
Beavo, J.A., and Rudensky, A.Y. (2007). Foxp3-dependent programme of
regulatory T-cell differentiation. Nature 445, 771–775.
Hoffmann, P., Boeld, T.J., Eder, R., Huehn, J., Floess, S., Wieczorek, G., Olek,
S., Dietmaier, W., Andreesen, R., and Edinger, M. (2009). Loss of FOXP3
expression in natural human CD4+CD25+ regulatory T cells upon repetitive
in vitro stimulation. Eur. J. Immunol. 39, 1088–1097.
Izcue, A., Coombes, J.L., and Powrie, F. (2006). Regulatory T cells suppress
systemic and mucosal immune activation to control intestinal inflammation.
Immunol. Rev. 212, 256–271.
Kawai, T., and Akira, S. (2007). TLR signaling. Semin. Immunol. 19, 24–32.
Li, B., Samanta, A., Song, X., Iacono, K.T., Bembas, K., Tao, R., Basu, S., Riley,
J.L., Hancock, W.W., Shen, Y., et al. (2007). FOXP3 interactions with histone
acetyltransferase and class II histone deacetylases are required for repression.
Proc. Natl. Acad. Sci. USA 104, 4571–4576.
Li, X., Huang, M., Zheng, H., Wang, Y., Ren, F., Shang, Y., Zhai, Y., Irwin, D.M.,
Shi, Y., Chen, D., and Chang, Z. (2008). CHIP promotes Runx2 degradation
and negatively regulates osteoblast differentiation. J. Cell Biol. 181, 959–972.
Lopes, J.E., Torgerson, T.R., Schubert, L.A., Anover, S.D., Ocheltree, E.L.,
Ochs, H.D., and Ziegler, S.F. (2006). Analysis of FOXP3 reveals multiple
domains required for its function as a transcriptional repressor. J. Immunol.
177, 3133–3142.
Luo, W., Zhong, J., Chang, R., Hu, H., Pandey, A., and Semenza, G.L. (2010).
Hsp70 and CHIP selectively mediate ubiquitination and degradation of
hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha. J. Biol. Chem.
285, 3651–3663.
Maldonado, R.A., and von Andrian, U.H. (2010). How tolerogenic dendritic
cells induce regulatory T cells. Adv. Immunol. 108, 111–165.
Matzinger, P. (2007). Friendly and dangerous signals: is the tissue in control?
Nat. Immunol. 8, 11–13.
Milkova, L., Voelcker, V., Forstreuter, I., Sack, U., Anderegg, U., Simon, J.C.,
and Maier-Simon, C. (2010). The NF-kappaB signalling pathway is involved
in the LPS/IL-2-induced upregulation of FoxP3 expression in human
CD4+CD25high regulatory T cells. Exp. Dermatol. 19, 29–37.
Miyao, T., Floess, S., Setoguchi, R., Luche, H., Fehling, H.J., Waldmann, H.,
Huehn, J., and Hori, S. (2012). Plasticity of Foxp3(+) T cells reflects promiscu-
ous Foxp3 expression in conventional T cells but not reprogramming of regu-
latory T cells. Immunity 36, 262–275.
Mougiakakos, D., Johansson, C.C., Jitschin, R., Bo¨ttcher, M., and Kiessling, R.
(2011). Increased thioredoxin-1 production in human naturally occurring
regulatory T cells confers enhanced tolerance to oxidative stress. Blood
117, 857–861.
Nagar, M., Vernitsky, H., Cohen, Y., Dominissini, D., Berkun, Y., Rechavi, G.,
Amariglio, N., and Goldstein, I. (2008). Epigenetic inheritance of DNA methyl-
ation limits activation-induced expression of FOXP3 in conventional human
CD25-CD4+ T cells. Int. Immunol. 20, 1041–1055.
Nishikawa, H., and Sakaguchi, S. (2010). Regulatory T cells in tumor immunity.
Int. J. Cancer 127, 759–767.Ohkura, N., Kitagawa, Y., and Sakaguchi, S. (2013). Development and main-
tenance of regulatory T cells. Immunity 38, 414–423.
Pan, F., Yu, H., Dang, E.V., Barbi, J., Pan, X., Grosso, J.F., Jinasena, D.,
Sharma, S.M., McCadden, E.M., Getnet, D., et al. (2009). Eos mediates
Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science 325,
1142–1146.
Powrie, F., Leach, M.W., Mauze, S., Caddle, L.B., and Coffman, R.L. (1993).
Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic
intestinal inflammation in C. B-17 scid mice. Int. Immunol. 5, 1461–1471.
Rubtsov, Y.P., Niec, R.E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist,
C., and Rudensky, A.Y. (2010). Stability of the regulatory T cell lineage in vivo.
Science 329, 1667–1671.
Sakaguchi, S., Vignali, D.A., Rudensky, A.Y., Niec, R.E., and Waldmann, H.
(2013). The plasticity and stability of regulatory T cells. Nat. Rev. Immunol.
13, 461–467.
Schroder, K., and Tschopp, J. (2010). The inflammasomes. Cell 140, 821–832.
Shi, Y., Evans, J.E., and Rock, K.L. (2003). Molecular identification of a danger
signal that alerts the immune system to dying cells. Nature 425, 516–521.
Tattevin, P., Monnier, D., Tribut, O., Dulong, J., Bescher, N., Mourcin, F., Uhel,
F., Le Tulzo, Y., and Tarte, K. (2010). Enhanced indoleamine 2,3-dioxygenase
activity in patients with severe sepsis and septic shock. J. Infect. Dis. 201,
956–966.
Tsuji, M., Komatsu, N., Kawamoto, S., Suzuki, K., Kanagawa, O., Honjo, T.,
Hori, S., and Fagarasan, S. (2009). Preferential generation of follicular B helper
T cells from Foxp3+ T cells in gut Peyer’s patches. Science 323, 1488–1492.
van Loosdregt, J., Fleskens, V., Fu, J., Brenkman, A.B., Bekker, C.P.J., Pals,
C.E.G.M., Meerding, J., Berkers, C.R., Barbi, J., Gro¨ne, A., et al. (2013).
Stabilization of the transcription factor Foxp3 by the deubiquitinase
USP7 increases Treg-cell-suppressive capacity. Immunity 39, this issue,
259–271.
Xu, L., Kitani, A., Fuss, I., and Strober, W. (2007). Cutting edge: regulatory
T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become
Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 178, 6725–
6729.
Yang, L., Anderson, D.E., Baecher-Allan, C., Hastings, W.D., Bettelli, E.,
Oukka, M., Kuchroo, V.K., and Hafler, D.A. (2008). IL-21 and TGF-beta are
required for differentiation of human T(H)17 cells. Nature 454, 350–352.
Zheng, Y., Josefowicz, S.Z., Kas, A., Chu, T.T., Gavin, M.A., and Rudensky,
A.Y. (2007). Genome-wide analysis of Foxp3 target genes in developing and
mature regulatory T cells. Nature 445, 936–940.
Zheng, Q., Xu, Y., Liu, Y., Zhang, B., Li, X., Guo, F., and Zhao, Y. (2009).
Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells
and prevents the occurrence of diabetes in mice. J. Mol. Med. 87, 1191–1205.
Zhou, X., Bailey-Bucktrout, S., Jeker, L.T., and Bluestone, J.A. (2009).
Plasticity of CD4(+) FoxP3(+) T cells. Curr. Opin. Immunol. 21, 281–285.Immunity 39, 272–285, August 22, 2013 ª2013 Elsevier Inc. 285
